As the chronic lymphocytic leukemia (CLL) treatment landscape evolves, how can CLL healthcare professionals better understand mutation profiles, including the emergence of novel CLL mutations over time? Are there any innovative approaches transforming CLL side effect management? How can barriers in CLL practice be removed to improve physician-patient communication and shared decision-making?
Dr. Jennifer Brown of the Dana-Farber Cancer Institute and Dr. Callie Coombs of the University of California, Irvine, draw from their expertise to illuminate and answer these questions. Learn about best practices for empowering your patients through effective side effect management and a deeper understanding of their CLL.
Topics:
- Complexities of CLL Mutations: Clonal Evolution and Resistance Mechanisms in CLL
- Eliminating Barriers in CLL Practice to Enhance Physician-Patient Communication and Facilitate Shared Decision-Making
- HCP-to-HCP Strategies for CLL Side Effect Management
Register to watch online on Tuesday, July 16th @ 10 AM Pacific | 1 PM Eastern. This roundtable is moderated by a HCP.
The webinar will be recorded. If you would like to share it with others, the replay will be available within the next few days. To receive a link to the recording, please register and you will be notified when it’s available.
I'll be at the July 16th HCP Roundtable: Exploring CLL Mutations and Best Practices for Side Effect Management webinar. Join me! Share on XGuests
Advocacy Parters
 |
 |
 |
 |
 |
 |
Empowering Providers to Empower Patients (EPEP) is brought to you by the Patient Empowerment Network. Funding is made possible through a sponsorship from Pharmacyclics, an AbbVie Company, and generous donations from people like you.
